HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of acute paroxysmal supraventricular tachycardia in pregnancy.

Abstract
The treatment of paroxysmal supraventricular tachycardia (PSVT) in pregnancy is not unlike treatment for the general population. The physician should feel confident that the pharmacologic agents ordinarily used to treat this common problem in the general population are safe for both mother and fetus when administered under monitored conditions. In treating paroxysmal supraventricular tachycardia in pregnancy, when both vagal maneuvers and exhaustive medical therapy fail, synchronized, direct-current cardioversion is a safe and effective form of treatment.
AuthorsB Pahlow, A K Geisler, G H Davis
JournalThe Journal of the American Osteopathic Association (J Am Osteopath Assoc) Vol. 91 Issue 1 Pg. 51-2, 57, 61-2 (Jan 1991) ISSN: 0098-6151 [Print] United States
PMID1997460 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Anti-Arrhythmia Agents (therapeutic use)
  • Combined Modality Therapy
  • Electric Countershock
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (therapy)
  • Tachycardia, Paroxysmal (therapy)
  • Tachycardia, Supraventricular (therapy)
  • Valsalva Maneuver

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: